Fourteenth International Congress on Spondyloarthritides

2024-8-29

No seasonal trends in referrals for vascular investigations: insight into the diagnosis of Raynaud's phenomenon and systemic sclerosis

2024-8-14

A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale

2024-8-14

The burden and determinants of fatigue in incident and prevalent systemic sclerosis

2024-8-14

Comparison of serum exosome miRNA from patients with Raynaud's phenomenon with positive and negative serum antinuclear antibodies

2024-8-14

Efficacy of intravenous immunoglobulins in severe scleromyxedema dysphagia assessed by oesophageal scintigraphy

2024-8-14

Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)

2024-8-14

Gastrointestinal disorders in systemic sclerosis: cluster analysis and prognosis from a French prospective cohort

2024-8-14

Assessment of fertility and sexual dysfunction in women with systemic sclerosis: a narrative review of the literature

2024-8-14

Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index

2024-8-14

Systemic sclerosis and environment: an intriguing and still debated association

2024-8-13

Efficacy of physiotherapy treatment in medium and long term in adults with fibromyalgia: an umbrella of systematic reviews

2024-7-4

Evolution of bone mineral density after 5 years of TNF-alpha inhibitors in axial spondyloarthritis.

2024-7-4

Delay in fibromyalgia diagnosis and its impact on the severity and outcome: a large cohort study

2024-7-4

High prevalence of orofacial pain in juvenile fibromyalgia as detected by a novel tool specifically devised for children and adolescents

2024-7-4

Beyond pain: the influence of psychological factors on functional status in fibromyalgia

2024-7-4

Anabolic treatment for osteoporosis and fragility fracture risk: one year in review 2024

2024-7-1

Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis

2024-6-17

Mapping in healthy subjects different body areas for dermal thickness and skin hardness by high frequency ultrasound and durometry

2024-6-5

Systemic sclerosis and inflammatory myopathy after treatment with durvalumab in a patient with rectal neoplasm

2024-5-29

Biopsy-proven giant cell arteritis in a patient with ankylosing spondylitis: a rare coincidence of two diseases at different stages of life

2024-5-22

Catastrophic antiphospholipid syndrome with massive cerebral venous sinus thrombosis

2024-5-14

Environment and systemic lupus erythematosus

2024-5-14

Novel insights into the management of rheumatoid arthritis: one year in review 2024

2024-5-14

A proposed clinical tool to identify high-risk patients for monogenic lupus: a pilot study

2024-5-7

The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases

2024-5-6

Markedly elevated serum IL-6 levels predict relapse within six months of treatment initiation in Still's disease

2024-5-5

Tailored exercise programmes for fibromyalgia: a clinical practical guide

2024-5-3

Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey

2024-4-29

The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients

2024-4-29

Systemic vasculitis: one year in review 2024

2024-4-29

Carotid artery ultrasonography and shear wave elastography in Takayasu's arteritis: a comparative analysis with diabetes mellitus

2024-4-25

The impact of environmental factors on aetiopathogenesis and clinical manifestations of Behçet's syndrome

2024-4-25

The birth of Environmental Rheumatology

2024-4-24

Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient

2024-4-23

Systemic sclerosis: one year in review 2024

2024-4-15

Interleukin-18 binding protein regulates mast cell activation and mast cell induced osteoclastogenesis of rheumatoid arthritis

2024-4-14

The association between rheumatoid arthritis and left ventricular diastolic dysfunction: pathogenesis, predictors and managements

2024-4-9

Efficacy and safety of neridronate in paediatric type I complex regional pain syndrome: a multicentre experience

2024-4-8

Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors

2024-4-7

Evaluation of epicardial adipose tissue thickness and carotid intima-media thickness in children with Behçet's disease

2024-4-6

Cocaine-induced nasal/paranasal, ocular and central nervous system ANCA-associated vasculitis resolved with steroids and cocaine withdrawal

2024-4-5

Haptoglobin blood assay to assess treatment compliance in rheumatoid arthitis patients treated with tocilizumab

2024-4-4

Effect of fibromyalgia on demographic, biochemical, metabolic and inflammatory profiles: a single-centre retrospective study

2024-4-1

Mitochondrial structural alterations in fibromyalgia: a pilot electron microscopy study

2024-3-30

A preliminary investigation of dissociation between subjective cognitive complaints and objective cognitive impairments in female patients with fibromyalgia: a role of information processing speed

2024-3-28

A rare presentation of granulomatosis with polyangiitis with prostate involvement

2024-3-23

Brepocitinib, a potent and selective TYK2/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis

2024-3-23

Reply to: Characterisation of crevicular fluid microbiota in primary Sjögren's disease

2024-3-21

The prevalence, epidemiological characteristics and mortality trends of inflammatory myopathies patients in Oman: the Prevision study

2024-3-18